Phacilitate Leaders World 

Industry Content

Industry Content

Welcome to the Industry Content Hub 

This is where you'll find all there is to know about our industry. Infographics, interviews, whitepapers and articles - we've got it all!
 

VIDEOS

REPORTS & ARTICLES

INTERVIEWS

phacilitate leaders world

Technology Review: Gene Editing

Edition One of Phacilitate's technology review series examines gene editing approaches by viral and non-viral methods 

phacilitate leaders world

60 seconds with Detlev Parow

A payer's perspective on CAR-T pricing and reimbursement with Detlev Parow,  Head of Patient Care Management at DAK-Gesundheit

phacilitate leaders world

What's next for Commercial Cell Therapy Manufacturing?

Panellists from Invetech, Bluebird Bio, Juno Therapeutics and Hitachi Chemical Advanced Therapeutics Solutions (HCATS) discuss their vision for the coming era of industrialised cell therapy production at Phacilitate Leaders World 2019, Miami

phacilitate leaders world

60 seconds with Michael Meyers

Ahead of his discussion regarding the next 15 years for advanced therapies at Phacilitate Leaders World 2019, Phacilitate caught up with Michael Meyers of T.R. Winston & Company, to find out what key takeaways attendees can expect from his session

phacilitate leaders world

Behind the Scenes at Phacilitate Leaders World 2019

1,600 industry leaders, academics, healthcare professionals, investors and so many more have gathered in downtown Miami for the 15th annual Phacilitate Leaders World and 14th annual World Stem Cell Summit for four days of sharing knowledge, partnering and collaborating.

phacilitate leaders world

Phacilitate Automation SIG 2018 Report

This report is comprised of 12 chapters dedicated to the most pressing issues discussed onsite at Phacilitate Automation SIG supported by in-depth commentary from the session rapporteurs on what this means for both you as an individual and the wider industry over the next 12 months. 

phacilitate leaders world

Demystifying the Common Technical Document

The Common Technical Document can sometimes be a bit daunting. As a fundamental part of the approval process for your product, whether you are a huge multinational corporation or a small biotech company, it is essential to know how to use the CTD

phacilitate leaders world

The Clinician's Perspective on Patient Access

The realities of administering advanced therapies in the clinic is our industry's next big challenge. So, what is the clinician's perspective on what's needed to effectively and safely bring advanced therapies to patients?

phacilitate leaders world

Advanced Therapies Investment Report

This report provides a comprehensive guide to successfully investing in advanced therapies. It also outlines across six chapters each of the challenges and opportunities of this sector for investors. Produced in partnership with Biotech and Money

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK